Filtern
Erscheinungsjahr
Dokumenttyp
- Zeitschriftenartikel (34)
- Beitrag zu einem Tagungsband (11)
- Beitrag zu einem Sammelband (5)
- Sonstiges (3)
- Forschungsbericht (3)
Schlagworte
- Biomarkers (7)
- Pharmaceuticals (6)
- Bivalves (5)
- ELISA (5)
- Brückenbeläge (4)
- Carbamazepine (4)
- Fahrbahnübergänge (4)
- Immunoassay (4)
- Oxidative stress (4)
- Pharmaceutical drugs (4)
Organisationseinheit der BAM
- 1 Analytische Chemie; Referenzmaterialien (10)
- 1.8 Umweltanalytik (10)
- 7 Bauwerkssicherheit (4)
- 7.1 Baustoffe (4)
- 6 Materialchemie (2)
- 8 Zerstörungsfreie Prüfung (2)
- 1.5 Proteinanalytik (1)
- 1.9 Chemische und optische Sensorik (1)
- 4 Material und Umwelt (1)
- 4.1 Biologische Materialschädigung und Referenzorganismen (1)
Under the auspices of the Protein Analysis Working Group (PAWG) of the Comité Consultatif pour la Quantité de Matière (CCQM) a pilot study, CCQM-P216, was coordinated by the Chinese National Institute of Metrology (NIM), National Research Council of Canada (NRC) and the Bureau International des Poids et Mesures (BIPM). Eleven Metrology Institutes or Designated Institutes and the BIPM participated in the first phase of the pilot study (Part 1). The purpose of this pilot study was to develop measurement capabilities for larger proteins using a recombinant humanized IgG monoclonal antibody against Spike glycoprotein of SARS-CoV-2 (Anti-S IgG mAb) in solution. The first phase of the study was designed to employ established methods that had been previously studies by the CCQM Protein Analysis Working Group, involving the digestion of protein down to the peptide or amino acid level. The global coronavirus pandemic has also led to increased focus on antibody quantitation methods. IgG are among the immunoglobulins produced by the immune system to provide protection against SARS-CoV-2. Anti-SARS-CoV-2 IgG can therefore be detected in samples from affected patients. Antibody tests can show whether a person has been exposed to the SARS-CoV-2, and whether or not they potentially show lasting immunity to the disease. With the constant spread of the virus and the high pressure of re-opening economies, antibody testing plays a critical role in the fight against COVID-19 by helping healthcare professionals to identify individuals who have developed an immune response, either via vaccination or exposure to the virus. Many countries have launched large-scale antibody testing for COVID-19. The development of measurement standards for the antibody detection of SARS-CoV-2 is critically important to deal with the challenges of the COVID-19 pandemic. In this study, the SARS-CoV-2 monoclonal antibody is being used as a model system to build capacity in methods that can be used in antibody quantification. Amino acid reference values with corresponding expanded uncertainty of 36.10 ± 1.55 mg/kg, 38.75 ± 1.45 mg/kg, 18.46 ± 0.78 mg/kg, 16.20 ± 0.67 mg/kg and 30.61 ± 1.30 mg/kg have been established for leucine, valine, phenylalanine, isoleucine and proline, respectively. Agreement between nearly all laboratories was achieved for the amino acid analysis within 2 to 2.5 %, with one participant achieving markedly higher results due to a technical issue found in their procedure; this result was thus excluded from the reference value calculations. The relatively good agreement within a laboratory between different amino acids was not dissimilar to previous results for peptides or small proteins, indicating that factors such as hydrolysis conditions and calibration procedures could be the largest sources of variability. Peptide reference values with corresponding expanded uncertainty of 4.99 ± 0.28 mg/kg and 6.83 ± 0.65 mg/kg have been established for ALPAPIEK and GPSVFPLAPSSK, respectively. Not surprisingly due to prior knowledge from previous studies on peptide quantitation, agreement between laboratories for the peptide-based analysis was slightly poorer at 3 to 5 %, with one laboratory's result excluded for the peptide GPSVFPLAPSSK. Again, this level of agreement was not significantly poorer than that achieved in previous studies with smaller or less complex proteins. To reach the main text of this paper, click on Final Report.
Diese Hinweisbroschüre erläutert allgemeine Planungsvoraussetzungen und Dimensionierungsregelungen, Baugrundsätze und Zulassungsbedingungen zur Anwendung innovativer Belagsdehnfugensysteme (Fahrbahnübergangskonstruktionen) in hochbeanspruchten Verkehrsflächen des Bundesfernstraßenbereiches. Alle planungsrelevanten, baustoffrelevanten, versuchstechnische, qualitätssichernden und baupraktischen Aspekte werden zur Unterstützung der Straßenbauverwaltungen, der Lieferfirmen und Ausführungsbetriebe erläutert. Die Veröffentlichung stellt eine technische Analyse aus Erfahrungssammlungen und Auswertung praktischer Erkenntnisse dar.
Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications
(2015)
Targeting photosensitizers to cancer cells by conjugating them with specific antibodies, able to recognize and bind to tumor-associated antigens, is today one of the most attractive strategies in photodynamic therapy (PDT). This comprehensive review updates on chemical routes available for the preparation of photo-immunoconjugates (PICs), which show dual chemical and biological functionalities: photo-properties of the photosensitizer and the immunoreactivity of the antibody. Moreover, photobiological results obtained with such photo-immunoconjugates using in vitro and in vivo cancer models are also discussed.
The synthesis of a novel PS conjugated with bovine and human serum albumin (BSA and HSA) and a monoclonal antibody anti-CD104 is reported, as well as their biological potential against the human bladder cancer cell line UM-UC-3. No photodynamic effect was detected when the non-conjugated porphyrin was used. Yet, when it was coupled covalently with the mAb anti-CD104, BSA and HSA, the resulting photosensitizer conjugates demonstrated high efficacy in destroying the cancer cells, the mAb anti-CD104 efficacy overruling the albumins.
Selective Catalytic Reduction of Nitric Oxide by Ammonia over Egg-Shell MnOx/NaY Composite Catalysts
(2002)
A novel composite catalyst system for the selective catalytic reduction (SCR) of NOx by NH3 is described operating at temperatures lower than 470 K in the presence of water with NO conversions of 80100% at space velocities of 30,00050,000 h-1. The catalyst is prepared by egg-shell precipitation of MnO2 on the external surface of zeolite NaY. Structural and thermal stability of precipitated MnO2 as well as of the MnO2/NaY composite catalyst were characterized by N2 adsorption, X-ray diffraction, laser Raman spectroscopy, temperature-programmed reduction, and electron microscopy. MnO2 precipitated on zeolite NaY (15 wt% loading) retained its amorphous state up to calcination temperatures of 775 K. The zeolite component remained structurally intact. Calcination at higher temperatures destroyed the zeolite structure and transformed MnO2 into Mn3O4. DRIFT spectroscopic investigations revealed the presence of symmetric O=NON=O species formally corresponding to N2O3 on the composite catalyst after contact with NO. Catalytic measurements under integral flow conditions showed that the catalyst performance is associated with a close coupling of nitrite formation and its drain off from equilibria with NO/NO2 and nitrate by ammonia. Several results are in line with the diazotation mechanism, including NH3 protonation to NH4+, whereas prevailing Lewis acid sites should enable NH3 activation via amide species, thus leading to a parallel amide/nitrosamide SCR reaction route. The activity-temperature profile fulfills the requirements of a low-temperature NOx reduction catalyst for mobile diesel engines if an ammonia supply is implemented on board, e.g., by urea decomposition.